Which hypertension guidelines must be followed by Brazilian physicians. A comparative analysis of the Brazilian, European and North American guidelines;Qual a diretriz de hipertensão arterial os, médicos brasileiros devem seguir? Análise comparativa das diretrizes, Brasileiras, Européias e Norte-Americanas (JNC VII)

Arquivos Brasileiros de Cardiologia

Volumn 83, Issue 2, 2004, Pages 179-181

  Vieira Da Silva, Giovanio ^a,b   Mion Jr , Décio ^a,b,c   Mota Gomes, Marco Antônio ^a,b   Machado, Carlos Alberto ^a,b   Praxedes, José Nery ^a,b   Amodeo, Celso ^a,b   Nobre, Fernando ^a,b   Kohlmann Jr , Oswaldo ^a,b  

^a Comissao Permanente IV Diretrizes B ^*

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Inst Central do HC   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BODY MASS; BRAZIL; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL PRACTICE; DIABETES MELLITUS; EUROPE; HUMAN; HYPERTENSION; NORTH AMERICA; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; UNITED STATES;

BRAZIL; EUROPE; GUIDELINE ADHERENCE; HUMANS; HYPERTENSION; PRACTICE GUIDELINES; RISK FACTORS; UNITED STATES;

EID: 4344668451     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. IV Diretrizes Brasileiras de Hipertensão Arterial. 2002.
2. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289: 2560-72.
3. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003; 21: 1011-53.
4. Freitag MH, Vasan R. What is normal blood pressure? Current Opin Nephrol Hypertens. 2003; 2: 285-92.
5. Kannel WB, Vasan RS, Levy D. Is the relation of systolic blood pressure to risk of cardiovascular disease continuos and graded, or are there critical values?. Hypertension. 2003; 42: 453-56.
6. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analisys of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903-13.
7. Brookes L. The response at ASH to the new JNC 7 guidelines. www.medscape.com/ viewarticle/455929 acessado em 04/06/2003.
8. Vasan RS, Larson MG, Laip EP, Kannel WB, Levy D. Assessement of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001; 358: 1682-6.
9. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure and risk of cardiovascular disease. N Engl J Med. 2001; 345: 1291-97.
10. Mancia G. Discusses the 2003 ESH/ESC hypertension guidelines. www.medscape.com/viewprogram/2520_ptn acessado em 2/7/2003.
11. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure Arch Intern Med. 1997; 157: 2413-46.
12. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blockervs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2003; 288: 2981-97.
13. Siragy HM. ALLHAT: Do we have all the answers? Curr Hypertens Rep. 2003; 5: 293-4.